• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清脂质筛查以识别冠心病死亡的高危个体。脂质研究临床患病率队列研究结果。

Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort.

作者信息

Grover S A, Palmer C S, Coupal L

机构信息

Centre for the Analysis of Cost-Effective Care, Montreal Quebec General Hospital.

出版信息

Arch Intern Med. 1994 Mar 28;154(6):679-84.

PMID:8129502
Abstract

OBJECTIVE

To assess the accuracy of specific plasma lipid fractions in predicting coronary heart disease (CHD) mortality among adults.

METHODS

Follow-up data for a random sample of 30- to 79-year-old men and women recruited into the Lipid Research Clinics Prevalence and Follow-up Studies were included in this analysis (n = 4499). Baseline measurements of total plasma cholesterol and lipoprotein fractions were compared with subsequent CHD mortality after a mean follow-up of 12.3 years. The areas under receiver operating characteristics curves for specific serum lipids were compared for individuals aged 30 to 59 and 60 to 79 years.

MAIN RESULTS

For the younger cohort, the ratio of total cholesterol to high-density lipoprotein cholesterol was a better predictor (P < .05) of CHD mortality (receiver operating characteristic curve area, 0.80 +/- 0.03) than was total cholesterol level alone (receiver operating characteristic curve area, 0.73 +/- 0.03) or any other single lipoprotein measurement. Among the older cohort, the same screening strategies performed poorly, with receiver operating characteristic curve areas ranging from 0.51 +/- 0.05 for total cholesterol to 0.64 +/- 0.05 for the ratio of low-density to high-density lipoprotein cholesterol levels.

CONCLUSION

Plasma lipid levels are poor predictors of coronary death among those aged 60 to 79 years without known CHD. These data indicate the need to define better lipid screening strategies for older, asymptomatic adults. Among younger adults aged 30 to 59 years, high-density lipoprotein cholesterol measurement should be included as part of any lipid screening program, as the ratio of total to high-density lipoprotein cholesterol levels is the best lipid screening test to identify those at high risk for subsequent CHD mortality.

摘要

目的

评估特定血浆脂质组分预测成人冠心病(CHD)死亡率的准确性。

方法

本分析纳入了脂质研究临床患病率和随访研究中随机抽取的30至79岁男性和女性的随访数据(n = 4499)。将血浆总胆固醇和脂蛋白组分的基线测量值与平均随访12.3年后的后续CHD死亡率进行比较。比较了30至59岁和60至79岁个体特定血清脂质的受试者工作特征曲线下面积。

主要结果

对于较年轻的队列,总胆固醇与高密度脂蛋白胆固醇的比值是CHD死亡率更好的预测指标(P <.05)(受试者工作特征曲线面积,0.80±0.03),优于单独的总胆固醇水平(受试者工作特征曲线面积,0.73±0.03)或任何其他单一脂蛋白测量值。在较年长的队列中,相同的筛查策略表现不佳,受试者工作特征曲线面积从总胆固醇的0.51±0.05到低密度与高密度脂蛋白胆固醇水平比值的0.64±0.05不等。

结论

在60至79岁无已知CHD的人群中,血浆脂质水平对冠状动脉死亡的预测能力较差。这些数据表明需要为年龄较大、无症状的成年人定义更好的脂质筛查策略。在30至59岁的较年轻成年人中,应将高密度脂蛋白胆固醇测量纳入任何脂质筛查项目,因为总胆固醇与高密度脂蛋白胆固醇水平的比值是识别后续CHD死亡高危人群的最佳脂质筛查测试。

相似文献

1
Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort.血清脂质筛查以识别冠心病死亡的高危个体。脂质研究临床患病率队列研究结果。
Arch Intern Med. 1994 Mar 28;154(6):679-84.
2
A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.老年人血脂水平与冠心病的长期随访研究
Chin Med J (Engl). 2004 Feb;117(2):163-7.
3
Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data.总血清胆固醇水平与作为年龄函数的死亡风险。一项基于弗雷明汉数据的报告。
Arch Intern Med. 1993 May 10;153(9):1065-73.
4
Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.载脂蛋白B、低密度脂蛋白胆固醇与男性冠心病的长期风险
Am J Cardiol. 2006 Apr 1;97(7):997-1001. doi: 10.1016/j.amjcard.2005.10.060. Epub 2006 Feb 13.
5
Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.在老年患者中,依折麦布联合他汀类药物持续治疗对改善血脂谱及实现低密度脂蛋白胆固醇目标的有效性:一项随机、双盲、安慰剂对照试验数据的亚组分析
Am J Geriatr Pharmacother. 2005 Dec;3(4):218-28.
6
Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.冠心病男性患者弥漫性动脉粥样硬化的相关因素及后果。退伍军人事务部高密度脂蛋白干预试验研究组。
Arch Intern Med. 1996 Jun 10;156(11):1181-8.
7
Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.空军/德克萨斯冠状动脉粥样硬化预防研究(AFCAPS/TexCAPS)队列亚组筛查期间血清低密度脂蛋白胆固醇水平的不稳定性。
J Am Osteopath Assoc. 2002 Jul;102(7):377-84.
8
A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.一项基于三级护理医院的针对已确诊冠状动脉疾病的常规风险因素(包括血脂谱)的研究。
Indian Heart J. 2003 May-Jun;55(3):234-40.
9
Relationship between plasma lipids and all-cause mortality in nondemented elderly.非痴呆老年人血浆脂质与全因死亡率之间的关系。
J Am Geriatr Soc. 2005 Feb;53(2):219-26. doi: 10.1111/j.1532-5415.2005.53106.x.
10
High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.高密度脂蛋白胆固醇与低密度脂蛋白胆固醇作为老年人冠状动脉疾病和中风的风险因素
Arch Intern Med. 2003 Jul 14;163(13):1549-54. doi: 10.1001/archinte.163.13.1549.

引用本文的文献

1
Modelling the direct and indirect associations between anthropometric and behavioural factors when predicting atherogenic risk index (TC/HDL-C) ratio.预测动脉粥样硬化风险指数(总胆固醇/高密度脂蛋白胆固醇比值)时,对人体测量学和行为因素之间的直接和间接关联进行建模。
Int J Obes (Lond). 2025 Jul 5. doi: 10.1038/s41366-025-01835-0.
2
High TG/HDL ratio suggests a higher risk of metabolic syndrome among an elderly Chinese population: a cross-sectional study.高甘油三酯/高密度脂蛋白比值提示中国老年人群代谢综合征风险增加:一项横断面研究。
BMJ Open. 2021 Mar 22;11(3):e041519. doi: 10.1136/bmjopen-2020-041519.
3
Ratio of triglyceride to high-density lipoprotein cholesterol and risk of major cardiovascular events in kidney transplant recipients.
肾移植受者中甘油三酯与高密度脂蛋白胆固醇的比值及主要心血管事件风险
Clin Exp Nephrol. 2019 Dec;23(12):1407-1417. doi: 10.1007/s10157-019-01776-9. Epub 2019 Aug 29.
4
Risk assessment of metabolic syndrome in adolescents using the triglyceride/high-density lipoprotein cholesterol ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.利用甘油三酯/高密度脂蛋白胆固醇比值和总胆固醇/高密度脂蛋白胆固醇比值评估青少年代谢综合征的风险
Ann Pediatr Endocrinol Metab. 2019 Mar;24(1):41-48. doi: 10.6065/apem.2019.24.1.41. Epub 2019 Mar 31.
5
Circulating lipid levels and risk of coronary artery disease in a large group of patients undergoing coronary angiography.一大组接受冠状动脉造影患者的循环脂质水平与冠状动脉疾病风险
J Thromb Thrombolysis. 2015 Jan;39(1):15-22. doi: 10.1007/s11239-014-1069-2.
6
Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention.脂蛋白比率:在心血管疾病预防中的生理意义及临床应用价值
Vasc Health Risk Manag. 2009;5:757-65. Epub 2009 Sep 18.
7
Cost effectiveness of preventive interventions in type 2 diabetes mellitus: a systematic literature review.2型糖尿病预防干预措施的成本效益:一项系统文献综述
Pharmacoeconomics. 2006;24(5):425-41. doi: 10.2165/00019053-200624050-00002.
8
Statins for primary prevention: at what coronary risk is safety assured?他汀类药物用于一级预防:在何种冠心病风险水平下安全性可得到保证?
Br J Clin Pharmacol. 2001 Oct;52(4):439-46. doi: 10.1046/j.0306-5251.2001.01478.x.
9
Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines.脂质筛查预防冠状动脉疾病:对不断演变的指南的定量评估。
CMAJ. 2000 Nov 14;163(10):1263-9.
10
Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study.医生能否准确评估患者的冠心病风险?冠心病健康评估研究的初步结果。
BMJ. 1995 Apr 15;310(6985):975-8. doi: 10.1136/bmj.310.6985.975.